Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:37:11.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed description of a clinical study evaluating ABP 654 compared to ustekinumab for plaque psoriasis, including study purpose, participant criteria, and study procedures. Additionally, the version number has been updated from v2.14.4 to v2.15.0.
    Difference
    24%
    Check dated 2025-04-16T14:41:27.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T09:40:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:28:50.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-24T20:59:12.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-10T09:54:09.000Z thumbnail image

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.